Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Open-label Study Of Cp-690,550 to Confirm The Safety Following Long Term Administration Of Cp-690,550 In The Treatment Of Rheumatoid Arthritis

NCT00661661 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00661661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00661661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Open-label Study Of Cp-690,550 to Confirm The Safety Following Long Term Administration Of Cp-690,550 In The Treatment Of Rheumatoid Arthritis
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2008
Completion date
December 31, 2013
Enrollment
487 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis